Voors, A. A., Mulder, H., Reyes, E., Cowie, M. R., Lassus, J., Hernandez, A. F., . . . Armstrong, P. W. (2021). Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: Insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial. European journal of heart failure, 23(8), 1313-1321. https://doi.org/10.1002/ejhf.2221
Chicago Style (17th ed.) CitationVoors, Adriaan A., et al. "Renal Function and the Effects of Vericiguat in Patients with Worsening Heart Failure with Reduced Ejection Fraction: Insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) Trial." European Journal of Heart Failure 23, no. 8 (2021): 1313-1321. https://doi.org/10.1002/ejhf.2221.
MLA (9th ed.) CitationVoors, Adriaan A., et al. "Renal Function and the Effects of Vericiguat in Patients with Worsening Heart Failure with Reduced Ejection Fraction: Insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) Trial." European Journal of Heart Failure, vol. 23, no. 8, 2021, pp. 1313-1321, https://doi.org/10.1002/ejhf.2221.